Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2768)
All Articles published online
|
Feb 7, 2005 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cheng SQ, Wang WL, Yan W, Li QL, Wang L, Wang WY. Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721. World J Gastroenterol 2005; 11(5): 756-759 [PMID: 15655839 DOI: 10.3748/wjg.v11.i5.756] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i5/756.htm |
| Number | Citing Articles |
| 1 |
Masaharu Tada, Etsuro Hatano, Kojiro Taura, Takashi Nitta, Naoki Koizumi, Iwao Ikai, Yasuyuki Shimahara. High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine. The Journal of Gene Medicine 2006; 8(8): 1018 doi: 10.1002/jgm.930
|
| 2 |
Renhua Guo, Zuhu Huang, Yongqian Shu, Shidai Jin, Hongmei Ge. Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression. Biomedicine & Pharmacotherapy 2009; 63(5): 375 doi: 10.1016/j.biopha.2008.09.010
|
| 3 |
Ezharul Hoque Chowdhury. Strategies for tumor-directed delivery of siRNA. Expert Opinion on Drug Delivery 2011; 8(3): 389 doi: 10.1517/17425247.2011.554817
|
| 4 |
Yuning Sun, Ruxian Lin, Jinming Dai, Dazhi Jin, Sheng-Qi Wang. Suppression of Tumor Growth Using Antisense Oligonucleotide Against Survivin in an Orthotopic Transplant Model of Human Hepatocellular Carcinoma in Nude Mice. Oligonucleotides 2006; 16(4): 365 doi: 10.1089/oli.2006.16.365
|
| 5 |
Sergio Huerta, Emily J. Goulet, Sara Huerta-Yepez, Edward H. Livingston. Screening and Detection of Apoptosis. Journal of Surgical Research 2007; 139(1): 143 doi: 10.1016/j.jss.2006.07.034
|
| 6 |
Azmat Ali Khan, Amer M. Alanazi, Mumtaz Jabeen, Arun Chauhan, Mohammad Azam Ansari. Therapeutic potential of functionalized siRNA nanoparticles on regression of liver cancer in experimental mice. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52142-4
|
| 7 |
Jens Bo Hansen, Niels Fisker, Majken Westergaard, Lene Sønderby Kjærulff, Henrik Frydenlund Hansen, Charlotte Albaek Thrue, Christoph Rosenbohm, Margit Wissenbach, Henrik Ørum, Troels Koch. SPC3042: a proapoptotic survivin inhibitor. Molecular Cancer Therapeutics 2008; 7(9): 2736 doi: 10.1158/1535-7163.MCT-08-0161
|
| 8 |
Renhua Guo, Tongshan Wang, Hua Shen, Hong-mei Ge, Jing Sun, Zu-hu Huang, Yong-qian Shu. Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2. Biomedicine & Pharmacotherapy 2010; 64(4): 249 doi: 10.1016/j.biopha.2009.06.007
|
| 9 |
Ja H. Ku, Soo Y. Seo, Cheol Kwak, Hyeon H. Kim. Cytotoxicity and apoptosis by survivin small interfering RNA in bladder cancer cells. BJU International 2010; 106(11): 1812 doi: 10.1111/j.1464-410X.2010.09259.x
|
| 10 |
Shiri Weinstein, Dan Peer. RNAi nanomedicines: challenges and opportunities within the immune system. Nanotechnology 2010; 21(23): 232001 doi: 10.1088/0957-4484/21/23/232001
|
| 11 |
Dan Peer. RNA Interference from Biology to Therapeutics. Advances in Delivery Science and Technology 2013; : 127 doi: 10.1007/978-1-4614-4744-3_6
|
| 12 |
|
| 13 |
Wenzhao Han, Ye Yuan, Hui Li, Zhendong Fu, Mingyang Wang, Shuwen Guan, Liping Wang. Design and anti-tumor activity of self-loaded nanocarriers of siRNA. Colloids and Surfaces B: Biointerfaces 2019; 183: 110385 doi: 10.1016/j.colsurfb.2019.110385
|
| 14 |
Gu Congmin, Zeng Mu, Ma Yihui, Lin Hanliang. Survivin—An attractive target for RNAi in non-Hodgkin's lymphoma, Daudi cell line as a model. Leukemia & Lymphoma 2006; 47(9): 1941 doi: 10.1080/10428190600725354
|
| 15 |
Han Bing, Wu Li-Qun, Ma Xiang, Wang Zheng-Hua, Li Jin-Peng, Bi Chong-Yao, Yong Sun. Synergistic Effect of IFN-γ Gene on LIGHT-induced Apoptosis in HepG2 Cells via Down Regulation of Bcl-2. Artificial Cells, Blood Substitutes, and Biotechnology 2011; 39(4): 228 doi: 10.3109/10731199.2010.538403
|
| 16 |
S I Pai, Y-Y Lin, B Macaes, A Meneshian, C-F Hung, T-C Wu. Prospects of RNA interference therapy for cancer. Gene Therapy 2006; 13(6): 464 doi: 10.1038/sj.gt.3302694
|
| 17 |
Li-Hua Hu, Ju-Hong Yang, De-Tai Zhang, Song Zhang, Lin Wang, Peng-Cheng Cai, Jian-Feng Zheng, Jin-Song Huang. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anti-Cancer Drugs 2007; 18(4): 427 doi: 10.1097/CAD.0b013e328013d99e
|
| 18 |
Ziqin Liu, Tianyou Wang, Zhaoxia Zhang, Suoqin Tang, Shunqiao Feng, Mei Yue, Mengze Hu, Litian Xuan, Yanfei Chen. Survivin downregulation using siRNA nanoliposomes inhibits cell proliferation and promotes the apoptosis of MHCC-97H hepatic cancer cells: An in vitro and in vivo study. Oncology Letters 2017; 13(4): 2723 doi: 10.3892/ol.2017.5754
|
| 19 |
D Peer, J Lieberman. Special delivery: targeted therapy with small RNAs. Gene Therapy 2011; 18(12): 1127 doi: 10.1038/gt.2011.56
|